These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898 [TBL] [Abstract][Full Text] [Related]
4. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso. Vogel G Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241 [No Abstract] [Full Text] [Related]
5. Risk of epidemic meningitis in Africa: a cause for concern. Wkly Epidemiol Rec; 2007 Mar; 82(10):79-87. PubMed ID: 17348094 [No Abstract] [Full Text] [Related]
6. Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012. Cibrelus L; Medah I; Koussoubé D; Yélbeogo D; Fernandez K; Lingani C; Djingarey M; Hugonnet S Emerg Infect Dis; 2015 Nov; 21(11):2063-6. PubMed ID: 26488128 [TBL] [Abstract][Full Text] [Related]
7. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Koumaré B; Ouedraogo-Traoré R; Sanou I; Yada AA; Sow I; Lusamba PS; Traoré E; Dabal M; Santamaria M; Hacen MM; Kaboré AB; Caugant DA Vaccine; 2007 Sep; 25 Suppl 1():A37-41. PubMed ID: 17521783 [TBL] [Abstract][Full Text] [Related]
9. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009. Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486 [No Abstract] [Full Text] [Related]
11. Immunisation update: Meningococcal B and ACWY vaccines. Davidson GT; Heaton PA; Paul SP J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934 [No Abstract] [Full Text] [Related]
12. Vaccination halts meningitis outbreak in Burkina Faso. Ahmad K Lancet; 2004 Apr; 363(9417):1290. PubMed ID: 15101377 [No Abstract] [Full Text] [Related]
13. [The outbreaks of invasive meningococcal disease in the municipalities of Goleniów and Przybiernów in March 2009. Control measures taken in the outbreak area]. Gatalska M; Marcinkowska BE; Opiela R; Sygit M Przegl Epidemiol; 2011; 65(3):429-32. PubMed ID: 22184943 [TBL] [Abstract][Full Text] [Related]
14. Meningococcal disease in New Zealand. Mills G; Bell A N Z Med J; 2013 Apr; 126(1373):10-1. PubMed ID: 23797072 [No Abstract] [Full Text] [Related]
15. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256 [TBL] [Abstract][Full Text] [Related]
17. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005. Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125 [No Abstract] [Full Text] [Related]
18. Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines. Oviedo-Orta E; Ahmed S; Rappuoli R; Black S Vaccine; 2015 Jul; 33(31):3628-35. PubMed ID: 26093201 [TBL] [Abstract][Full Text] [Related]
19. Serogroup B meningococcal disease: new outbreaks, new strategies. Wenger JD JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326 [No Abstract] [Full Text] [Related]
20. ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study. Sié A; Pflüger V; Coulibaly B; Dangy JP; Kapaun A; Junghanss T; Pluschke G; Leimkugel J Trop Med Int Health; 2008 Jun; 13(6):861-8. PubMed ID: 18384478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]